Last Updated on October 9, 2024 by The Health Master
New Delhi: Biocon is recalling 3,665 bottles of antifungal medication in the US market for “failed degradation specifications,” according to the US Food and Drug Administration (USFDA).
In its latest Enforcement Report, the US health regulator said that the Bengaluru-based firm is recalling 3,665 bottles of Posaconazole Delayed-Release Tablets (100 mg, 60-count bottle), used to treat serious fungal infections like invasive aspergillosis.
USFDA noted that the New Jersey-based Biocon Pharma Inc is recalling the affected lot due to “failed impurities/degradation specifications: high out-of-spec degradation results.”
The lot has been manufactured by Biocon Pharma and distributed in the US by Iselin-based Biocon Pharma Inc, it added.
Biocon initiated the Class II nationwide (US) recall on January 31, this year.
As per the USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
On February 12, Biocon stated that the USFDA has issued a Complete Response Letter (CRL) for the biologics licence application filed for Bevacizumab by its partner Viatris.
The USFDA issues a CRL to convey to a company that its initial review of an application is complete and it cannot approve the application in its present form.
Earlier on January 7, the company had stated that the USFDA has issued a complete response letter for Biocon Biologics’ application for Insulin-R, a proposed biosimilar for diabetes treatment.
Drug recall: Over 34,000 bottles of Diltiazem HCL capsules recalled due to this reason
Drug recall: 5,720 tubes of Clobetasol Propionate Cream recalled due to this reason
Drug recall: These Lots of Levothyroxine sodium Oral Solution recalled
Drug recall: Bharat Biotech voluntarily recalls ChiroRaba vaccine due to this reason
Drug recall: Rifampin Capsules recalled due to this reason
Drug recall: Epinephrine API recalled due to this reason
Medical Device alert: USFDA classifies recall of these devices as most serious
Govt asks Pharma Industry to go for QR code instead of SMS Code
USFDA gives tentative nod for these two generic drugs
NPPA asks industry to increase MRP after 12 months based on NLEM-2022
E-pharmacies under radar: Govt to initiate stern action
New guidelines for Blood Centres / Banks on bulk transfers: Maharashtra
FDA Haryana: Medical store sealed, drugs being sold at prices higher than MRP
Dissolution test: Importance in Pharma Industry
Updated list of Medical Device Testing Laboratories (MDTLs)
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
